share_log

Mineralys Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samsara BioCapital, L.P.(10.3%),Samsara BioCapital GP, LLC(10.3%), etc.

Mineralys Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Samsara BioCapital, L.P.(10.3%),Samsara BioCapital GP, LLC(10.3%)等

SEC announcement ·  02/12 16:51
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息